Latest Breaking News On - Nanosecond pulsed field ablation - Page 2 : comparemela.com

Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced that the Company’s Board of Directors has set the.

United statesCompany board of directorsExchange commissionCompany cellPulse biosciences incPulse biosciencesNanosecond pulsed field ablationCommon stockRecord dateRights offeringRegistration statementEastern timeEach unitAlternate priceInitial priceNano pulse stimulation

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced business updates and financial results for the.

United statesStefano spieziaVivek reddyKevin danahyExchange commissionCompany cellAmerican society for interventional thyroidologyPulse biosciences incCompany board of directorsPulse biosciencesNanosecond pulsed field ablationNorth american societyInterventional thyroidologyCardiac catheterRights offeringUniversal shelf

Pulse Biosciences Announces Plans to Initiate a Rights Offering

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ technology, today announced that its Board of Directors has unanimously approved.

United statesRobert dugganCompany cellCompany common stockExchange commissionPulse biosciences incPulse biosciencesNanosecond pulsed field ablationEach unitCommon stockRecord dateInitial priceExecutive chairmanNano pulse stimulationPulse bioscience

Pulse Biosciences submits market application for cardiac ablation device (NASDAQ:PLSE)

Pulse Biosciences submits market application for cardiac ablation device (NASDAQ:PLSE)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Andrzej rostekNanosecond pulsed field ablation

Pulse Biosciences, Inc (NASDAQ:PLSE) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Pulse Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

United statesPhilip taylorBob dugganJason smithStefan spieziaRalph tufanoBioscience cellDarrin ueckerRobert dugganMichael kofflerMitch levinsonUsman siddiquiKevin danahyRobert lovgrenStefano spieziaMitchell levinson